A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

Iloprost Effects on Gas Exchange and Pulmonary Mechanics

NCT01274481 ·Status: COMPLETED ·Phase: PHASE1

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

NCT06703073 ·Status: RECRUITING ·Phase: PHASE2

A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure

NCT02914665 ·Status: COMPLETED ·Phase: PHASE2

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

NCT05938036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Selonsertib in Adults With Pulmonary Arterial Hypertension

NCT02234141 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

NCT00455767 ·Status: COMPLETED ·Phase: PHASE2

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

NCT04357730 ·Status: COMPLETED ·Phase: PHASE2

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

NCT06701669 ·Status: RECRUITING ·Phase: PHASE2

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

NCT05947955 ·Status: RECRUITING ·Phase: PHASE2

Aerosol Inhalation Treatment for Dyspnea - Patients

NCT02524054 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT07181382 ·Status: SUSPENDED ·Phase: PHASE3

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

NCT03689244 ·Status: TERMINATED ·Phase: PHASE3

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

NCT06701656 ·Status: RECRUITING ·Phase: PHASE2

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

NCT07125079 ·Status: RECRUITING

Iloprost in Acute Respiratory Distress Syndrome

NCT03111212 ·Status: COMPLETED ·Phase: PHASE3

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

NCT00414687 ·Status: COMPLETED ·Phase: PHASE2

Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension

NCT03365479 ·Status: COMPLETED ·Phase: NA

Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.

NCT03078907 ·Status: COMPLETED ·Phase: PHASE4

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

NCT00323024 ·Status: WITHDRAWN ·Phase: PHASE2

Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults

NCT06564207 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

NCT03496623 ·Status: TERMINATED ·Phase: PHASE3

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

NCT04377620 ·Status: TERMINATED ·Phase: PHASE3

To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

NCT06038916 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

STATIN-VAP STATIN-VAP - STATINs and Ventilator-Associated Pneumonia

NCT01057758 ·Status: TERMINATED ·Phase: PHASE3

Efficacy of Ventavis Used in Real-life Setting.

NCT01355380 ·Status: COMPLETED